Interestingly, a clinical study recently reported a significant reduction of miR-146a and increased pro-inflammatory IL-8 in serum of type 2 diabetes patients compared to a non-diabetic control group22. This evidence concerns the gene CXCL8 and type 2 diabetes mellitus.